Rituximab (RTX) plus Methotrexate (MTX) prevents bone erosion and joint-space narrowing (JSN) and reduces synovitis, osteitis as shown on MRI: Results from a randomised, placebo-controlled trial in patients (PTS) with rheumatoid arthritis (RA-score).

C. Peterfy, P. Emery, P.-P. Tak, Mikkel Østergaard, J. DiCarlo, K. Otsa, F. Navarro Sarabia, K. Pavelka, K. Preston, T. Shaw, M.-A. Bagnard, A. Gabriele

    OriginalsprogEngelsk
    TidsskriftAnnals of the Rheumatic Diseases
    Vol/bind70
    Udgave nummer3 (Suppl.)
    Sider (fra-til)152
    Antal sider1
    ISSN0003-4967
    StatusUdgivet - 2011

    Citationsformater